BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer
Endometrial cancer (EC) rates are rising annually. Additional prediction markers need to be evaluated because only 10–20% of EC cases show an objective response to immune-checkpoint inhibitors (ICIs). Our previous methylomic study found that BHLHE22 is hypermethylated in EC tissues and can be detect...
Saved in:
Published in | International journal of molecular sciences Vol. 23; no. 13; p. 7158 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel
MDPI AG
28.06.2022
MDPI |
Subjects | |
Online Access | Get full text |
ISSN | 1422-0067 1661-6596 1422-0067 |
DOI | 10.3390/ijms23137158 |
Cover
Abstract | Endometrial cancer (EC) rates are rising annually. Additional prediction markers need to be evaluated because only 10–20% of EC cases show an objective response to immune-checkpoint inhibitors (ICIs). Our previous methylomic study found that BHLHE22 is hypermethylated in EC tissues and can be detected using a Pap-smear sample. BHLHE22, a basic helix loop helix transcription factor family member, is known as a transcriptional repressor and is involved in cell differentiation. However, the role of BHLHE22 in EC remains poorly understood. Herein, we analyzed BHLHE22 expression in 54 paired cancer and normal endometrial tissue samples, and confirmed with databases (TCGA, GTEx, and human protein atlas). We found that BHLHE22 protein expression was significantly downregulated in EC compared with normal endometrium. High BHLHE22 expression was associated with microsatellite-instable subtype, endometrioid type, grade, and age. It showed a significant favorable survival. BHLHE22 overexpression inhibited the proliferation and migration of EC cells. Functional enrichment analysis showed that BHLHE22 was significantly associated with immune-related pathways. Furthermore, BHLHE22 was positively correlated with proinflammatory leukocyte infiltration and expression of chemokine genes in EC. In conclusion, BHLHE22 regulates immune-related pathways and modulates the immune microenvironment of EC. |
---|---|
AbstractList | Endometrial cancer (EC) rates are rising annually. Additional prediction markers need to be evaluated because only 10–20% of EC cases show an objective response to immune-checkpoint inhibitors (ICIs). Our previous methylomic study found that BHLHE22 is hypermethylated in EC tissues and can be detected using a Pap-smear sample. BHLHE22, a basic helix loop helix transcription factor family member, is known as a transcriptional repressor and is involved in cell differentiation. However, the role of BHLHE22 in EC remains poorly understood. Herein, we analyzed BHLHE22 expression in 54 paired cancer and normal endometrial tissue samples, and confirmed with databases (TCGA, GTEx, and human protein atlas). We found that BHLHE22 protein expression was significantly downregulated in EC compared with normal endometrium. High BHLHE22 expression was associated with microsatellite-instable subtype, endometrioid type, grade, and age. It showed a significant favorable survival. BHLHE22 overexpression inhibited the proliferation and migration of EC cells. Functional enrichment analysis showed that BHLHE22 was significantly associated with immune-related pathways. Furthermore, BHLHE22 was positively correlated with proinflammatory leukocyte infiltration and expression of chemokine genes in EC. In conclusion, BHLHE22 regulates immune-related pathways and modulates the immune microenvironment of EC. Endometrial cancer (EC) rates are rising annually. Additional prediction markers need to be evaluated because only 10-20% of EC cases show an objective response to immune-checkpoint inhibitors (ICIs). Our previous methylomic study found that BHLHE22 is hypermethylated in EC tissues and can be detected using a Pap-smear sample. BHLHE22, a basic helix loop helix transcription factor family member, is known as a transcriptional repressor and is involved in cell differentiation. However, the role of BHLHE22 in EC remains poorly understood. Herein, we analyzed BHLHE22 expression in 54 paired cancer and normal endometrial tissue samples, and confirmed with databases (TCGA, GTEx, and human protein atlas). We found that BHLHE22 protein expression was significantly downregulated in EC compared with normal endometrium. High BHLHE22 expression was associated with microsatellite-instable subtype, endometrioid type, grade, and age. It showed a significant favorable survival. BHLHE22 overexpression inhibited the proliferation and migration of EC cells. Functional enrichment analysis showed that BHLHE22 was significantly associated with immune-related pathways. Furthermore, BHLHE22 was positively correlated with proinflammatory leukocyte infiltration and expression of chemokine genes in EC. In conclusion, BHLHE22 regulates immune-related pathways and modulates the immune microenvironment of EC.Endometrial cancer (EC) rates are rising annually. Additional prediction markers need to be evaluated because only 10-20% of EC cases show an objective response to immune-checkpoint inhibitors (ICIs). Our previous methylomic study found that BHLHE22 is hypermethylated in EC tissues and can be detected using a Pap-smear sample. BHLHE22, a basic helix loop helix transcription factor family member, is known as a transcriptional repressor and is involved in cell differentiation. However, the role of BHLHE22 in EC remains poorly understood. Herein, we analyzed BHLHE22 expression in 54 paired cancer and normal endometrial tissue samples, and confirmed with databases (TCGA, GTEx, and human protein atlas). We found that BHLHE22 protein expression was significantly downregulated in EC compared with normal endometrium. High BHLHE22 expression was associated with microsatellite-instable subtype, endometrioid type, grade, and age. It showed a significant favorable survival. BHLHE22 overexpression inhibited the proliferation and migration of EC cells. Functional enrichment analysis showed that BHLHE22 was significantly associated with immune-related pathways. Furthermore, BHLHE22 was positively correlated with proinflammatory leukocyte infiltration and expression of chemokine genes in EC. In conclusion, BHLHE22 regulates immune-related pathways and modulates the immune microenvironment of EC. |
Author | Chen, Lin-Yu Weng, Yu-Chun Wang, Hui-Chen Su, Po-Hsuan Darmawi Lai, Hung-Cheng Liew, Phui-Ly Huang, Rui-Lan |
AuthorAffiliation | 5 Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei 235, Taiwan; lilyliew@tmu.edu.tw 1 International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; d142108012@tmu.edu.tw 3 Department of Histology, Faculty of Medicine, Universitas Riau, Pekanbaru 28293, Indonesia 4 Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University, New Taipei 235, Taiwan 6 Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan 8 Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, National Defense Medical Center, Taipei 114, Taiwan 7 Department of Obstetrics and Gynecology, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; egg-0420@yahoo.com.tw 2 Translational Epigenetics Center, Shuang Ho Hospital, Taipei Medical University, New Taipei 235, Taiwan; maple916chen@gmail.com (L.-Y.C.); pohsuansu@gmail.com (P.-H. |
AuthorAffiliation_xml | – name: 7 Department of Obstetrics and Gynecology, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; egg-0420@yahoo.com.tw – name: 1 International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan; d142108012@tmu.edu.tw – name: 4 Department of Obstetrics and Gynecology, Shuang Ho Hospital, Taipei Medical University, New Taipei 235, Taiwan – name: 6 Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan – name: 5 Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei 235, Taiwan; lilyliew@tmu.edu.tw – name: 2 Translational Epigenetics Center, Shuang Ho Hospital, Taipei Medical University, New Taipei 235, Taiwan; maple916chen@gmail.com (L.-Y.C.); pohsuansu@gmail.com (P.-H.S.); kxther@gmail.com (Y.-C.W.); gyntsgh@gmail.com (R.-L.H.) – name: 8 Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, National Defense Medical Center, Taipei 114, Taiwan – name: 3 Department of Histology, Faculty of Medicine, Universitas Riau, Pekanbaru 28293, Indonesia |
Author_xml | – sequence: 1 orcidid: 0000-0001-5018-2381 surname: Darmawi fullname: Darmawi – sequence: 2 givenname: Lin-Yu orcidid: 0000-0003-4870-3664 surname: Chen fullname: Chen, Lin-Yu – sequence: 3 givenname: Po-Hsuan orcidid: 0000-0003-1114-6382 surname: Su fullname: Su, Po-Hsuan – sequence: 4 givenname: Phui-Ly orcidid: 0000-0003-2156-5628 surname: Liew fullname: Liew, Phui-Ly – sequence: 5 givenname: Hui-Chen surname: Wang fullname: Wang, Hui-Chen – sequence: 6 givenname: Yu-Chun surname: Weng fullname: Weng, Yu-Chun – sequence: 7 givenname: Rui-Lan surname: Huang fullname: Huang, Rui-Lan – sequence: 8 givenname: Hung-Cheng surname: Lai fullname: Lai, Hung-Cheng |
BookMark | eNptkc1uEzEUhS1URH9gxwNYYsOCUP9kPOMNUhulJFJQu4C15Rlft47GdrA9gT4Br42jVqitWF1L9ztH5_qcoqMQAyD0npLPnEty7rY-M055S5vuFTqhc8ZmhIj26Mn7GJ3mvCWEcdbIN-iYNx0RVLAT9OdytVktGcPL37sEObsY8Drji5zj4HQBg3-5coc1vknRBTtq73WJ6R6vvZ8C4G9uSBHC3qUYPISCdTB4EYOFlKvqSu9j0v0IB_1tiNll7AJeBhM9lOT0iBc6DJDeotdWjxnePc4z9ONq-X2xmm2uv64XF5vZwKksMyasmBsq5xIGoikIY5q2Z6IjYCyXtpXWUmEs5YII23WNFrxjPci2b_hgJD9DXx58d1PvwQw1ctKj2iXndbpXUTv1fBPcnbqNeyWZEJw01eDjo0GKPyfIRXmXBxhHHSBOWdUsbctI15KKfniBbuOUQj3vQAlaW6MHw08PVP3InBPYf2EoUYeG1dOGK85e4IMrutTealw3_l_0F0ZprLE |
CitedBy_id | crossref_primary_10_18632_aging_205414 crossref_primary_10_1016_j_tjog_2024_09_022 crossref_primary_10_1038_s43587_024_00757_2 crossref_primary_10_3389_fgene_2022_1002706 crossref_primary_10_3389_fonc_2024_1455255 |
Cites_doi | 10.1016/j.immuni.2019.08.013 10.1158/2326-6066.CIR-18-0442 10.1126/science.1129139 10.1126/science.aay5947 10.1186/s13148-019-0765-3 10.1038/s41587-020-0546-8 10.1038/ncomms3612 10.1016/j.cell.2015.03.030 10.1002/cncr.30094 10.3389/fonc.2019.01440 10.1126/science.1197454 10.1067/mai.2003.1594 10.3389/fgene.2021.654256 10.1016/S0140-6736(15)00130-0 10.1016/j.it.2020.09.002 10.1093/nar/gkx1090 10.1093/bioinformatics/btz931 10.1158/0008-5472.CAN-17-0307 10.1001/jamaoncol.2015.2151 10.3322/caac.21254 10.1007/s10552-018-1018-z 10.1056/NEJMoa1500596 10.1056/NEJMra1514010 10.21037/atm-21-6748 10.1136/jitc-2021-003777 10.1200/JCO.2017.72.5952 10.1006/geno.2002.6833 10.1016/j.cell.2016.04.009 10.1080/14737140.2018.1491311 10.7554/eLife.26476 10.1016/j.neuron.2011.09.035 10.1126/science.aan6733 10.1111/jcmm.15408 10.3389/fimmu.2019.00379 10.1016/j.semcancer.2022.02.017 10.1097/PGP.0000000000000106 10.3390/ijms20194705 10.3322/caac.21654 10.3892/mmr.2015.4070 10.1073/pnas.0506580102 10.1074/jbc.RA120.012753 10.1016/j.brainres.2018.03.013 10.1158/1078-0432.CCR-16-0863 10.1038/s41598-021-84787-5 10.2147/OTT.S324641 10.1038/nri.2017.49 10.1038/nature12113 10.1126/scisignal.2004088 |
ContentType | Journal Article |
Copyright | 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022 |
Copyright_xml | – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022 |
DBID | AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH K9. M0S M1P M2O MBDVC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8 5PM |
DOI | 10.3390/ijms23137158 |
DatabaseName | CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database Research Library Research Library (Corporate) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef Publicly Available Content Database Research Library Prep ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1422-0067 |
ExternalDocumentID | PMC9266305 10_3390_ijms23137158 |
GeographicLocations | United States--US |
GeographicLocations_xml | – name: United States--US |
GrantInformation_xml | – fundername: Ministry of Science and Technology, Taiwan grantid: MOST 110-2314-B-038-058; MOST 109-2314-B-038-052-MY3; MOST 110-2635-B-038-001; MOST 110-2314-B-038-060; MOST 109-2314-B-038-107-MY3 – fundername: Taipei Medical University, Taiwan grantid: TMU 108-AE1-B35 to R.-L.H. |
GroupedDBID | --- 29J 2WC 53G 5GY 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ 8G5 A8Z AADQD AAFWJ AAHBH AAYXX ABDBF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV AEAQA AENEX AFKRA AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BCNDV BENPR BPHCQ BVXVI CCPQU CITATION CS3 D1I DIK DU5 DWQXO E3Z EBD EBS EJD ESX F5P FRP FYUFA GNUQQ GUQSH GX1 HH5 HMCUK HYE IAO IHR ITC KQ8 LK8 M1P M2O M48 MODMG O5R O5S OK1 OVT P2P PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RNS RPM TR2 TUS UKHRP ~8M 3V. 7XB 8FK K9. MBDVC PJZUB PKEHL PPXIY PQEST PQUKI Q9U 7X8 ESTFP PUEGO 5PM |
ID | FETCH-LOGICAL-c319t-26f64d1949ec0a1e6dd57b2680edf39f79ff16df13606f885a6382be97b53cd93 |
IEDL.DBID | M48 |
ISSN | 1422-0067 1661-6596 |
IngestDate | Thu Aug 21 18:20:44 EDT 2025 Fri Sep 05 08:53:12 EDT 2025 Fri Jul 25 20:24:01 EDT 2025 Thu Apr 24 22:55:37 EDT 2025 Tue Jul 01 03:40:11 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 13 |
Language | English |
License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c319t-26f64d1949ec0a1e6dd57b2680edf39f79ff16df13606f885a6382be97b53cd93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-2156-5628 0000-0003-4870-3664 0000-0003-1114-6382 0000-0001-5018-2381 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ijms23137158 |
PMID | 35806162 |
PQID | 2686123115 |
PQPubID | 2032341 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9266305 proquest_miscellaneous_2687720870 proquest_journals_2686123115 crossref_primary_10_3390_ijms23137158 crossref_citationtrail_10_3390_ijms23137158 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20220628 |
PublicationDateYYYYMMDD | 2022-06-28 |
PublicationDate_xml | – month: 6 year: 2022 text: 20220628 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | Basel |
PublicationPlace_xml | – name: Basel |
PublicationTitle | International journal of molecular sciences |
PublicationYear | 2022 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Subramanian (ref_25) 2005; 102 Muley (ref_32) 2021; 12 Goldman (ref_46) 2020; 38 Nagy (ref_47) 2021; 11 Morice (ref_8) 2016; 387 Ross (ref_18) 2012; 73 Massara (ref_39) 2019; 10 Song (ref_31) 2021; 14 Wang (ref_38) 2016; 165 Siegel (ref_2) 2015; 65 Yoshihara (ref_27) 2013; 4 Huang (ref_15) 2017; 23 Li (ref_28) 2017; 77 Galon (ref_37) 2006; 313 Xu (ref_17) 2002; 80 Le (ref_12) 2015; 372 Ono (ref_36) 2003; 111 Li (ref_19) 2011; 331 Ge (ref_26) 2020; 36 Zhu (ref_33) 2022; 10 Li (ref_35) 2020; 24 Racle (ref_29) 2017; 6 Li (ref_24) 2019; 51 Fukuda (ref_20) 2015; 12 Nagarsheth (ref_41) 2017; 17 Ott (ref_13) 2017; 35 Connor (ref_7) 2018; 18 Lu (ref_9) 2020; 383 Cavallo (ref_22) 2015; 34 Whelan (ref_44) 2019; 7 Liew (ref_16) 2019; 11 Dennis (ref_34) 2019; 1705 Sharma (ref_42) 2015; 161 Zhong (ref_48) 2020; 367 Le (ref_30) 2017; 357 McAlpine (ref_4) 2016; 122 Oaknin (ref_14) 2022; 10 ref_43 Gao (ref_45) 2013; 6 Temkin (ref_5) 2018; 29 Levine (ref_10) 2013; 497 ref_40 Murata (ref_21) 2020; 295 Zhang (ref_1) 2019; 9 Howitt (ref_11) 2015; 1 Cook (ref_23) 2020; 41 Siegel (ref_3) 2021; 71 ref_6 Vasaikar (ref_49) 2018; 46 |
References_xml | – volume: 51 start-page: 491 year: 2019 ident: ref_24 article-title: The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8(+) T Cell Fitness and Functionality publication-title: Immunity doi: 10.1016/j.immuni.2019.08.013 – volume: 7 start-page: 257 year: 2019 ident: ref_44 article-title: PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8(+) T-cell Function publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-18-0442 – volume: 313 start-page: 1960 year: 2006 ident: ref_37 article-title: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome publication-title: Science doi: 10.1126/science.1129139 – volume: 367 start-page: eaay5947 year: 2020 ident: ref_48 article-title: An atlas of the protein-coding genes in the human, pig, and mouse brain publication-title: Science doi: 10.1126/science.aay5947 – volume: 11 start-page: 170 year: 2019 ident: ref_16 article-title: Combined genetic mutations and DNA-methylated genes as biomarkers for endometrial cancer detection from cervical scrapings publication-title: Clin. Epigenetics doi: 10.1186/s13148-019-0765-3 – volume: 38 start-page: 675 year: 2020 ident: ref_46 article-title: Visualizing and interpreting cancer genomics data via the Xena platform publication-title: Nat. Biotechnol. doi: 10.1038/s41587-020-0546-8 – volume: 4 start-page: 2612 year: 2013 ident: ref_27 article-title: Inferring tumour purity and stromal and immune cell admixture from expression data publication-title: Nat Commun doi: 10.1038/ncomms3612 – volume: 161 start-page: 205 year: 2015 ident: ref_42 article-title: Immune checkpoint targeting in cancer therapy: Toward combination strategies with curative potential publication-title: Cell doi: 10.1016/j.cell.2015.03.030 – volume: 122 start-page: 2787 year: 2016 ident: ref_4 article-title: Endometrial cancer: Not your grandmother’s cancer publication-title: Cancer doi: 10.1002/cncr.30094 – volume: 9 start-page: 1440 year: 2019 ident: ref_1 article-title: Global, Regional, and National Burden of Endometrial Cancer, 1990–2017: Results From the Global Burden of Disease Study, 2017 publication-title: Front. Oncol. doi: 10.3389/fonc.2019.01440 – volume: 331 start-page: 912 year: 2011 ident: ref_19 article-title: The antiproliferative action of progesterone in uterine epithelium is mediated by Hand2 publication-title: Science doi: 10.1126/science.1197454 – volume: 111 start-page: 1185 year: 2003 ident: ref_36 article-title: Chemokines: Roles in leukocyte development, trafficking, and effector function publication-title: J. Allergy Clin. Immunol. doi: 10.1067/mai.2003.1594 – volume: 12 start-page: 654256 year: 2021 ident: ref_32 article-title: Evolutionary Perspective and Expression Analysis of Intronless Genes Highlight the Conservation of Their Regulatory Role publication-title: Front. Genet. doi: 10.3389/fgene.2021.654256 – volume: 387 start-page: 1094 year: 2016 ident: ref_8 article-title: Endometrial cancer publication-title: Lancet doi: 10.1016/S0140-6736(15)00130-0 – volume: 41 start-page: 1023 year: 2020 ident: ref_23 article-title: Transcription Factor Bhlhe40 in Immunity and Autoimmunity publication-title: Trends Immunol. doi: 10.1016/j.it.2020.09.002 – volume: 46 start-page: D956 year: 2018 ident: ref_49 article-title: LinkedOmics: Analyzing multi-omics data within and across 32 cancer types publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkx1090 – volume: 36 start-page: 2628 year: 2020 ident: ref_26 article-title: ShinyGO: A graphical gene-set enrichment tool for animals and plants publication-title: Bioinformatics doi: 10.1093/bioinformatics/btz931 – volume: 77 start-page: e108 year: 2017 ident: ref_28 article-title: TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-17-0307 – volume: 1 start-page: 1319 year: 2015 ident: ref_11 article-title: Association of Polymerase e-Mutated and Microsatellite-Instable Endometrial Cancers With Neoantigen Load, Number of Tumor-Infiltrating Lymphocytes, and Expression of PD-1 and PD-L1 publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2015.2151 – volume: 65 start-page: 5 year: 2015 ident: ref_2 article-title: Cancer statistics, 2015 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21254 – volume: 29 start-page: 427 year: 2018 ident: ref_5 article-title: Hysterectomy-corrected rates of endometrial cancer among women younger than age 50 in the United States publication-title: Cancer Causes Control doi: 10.1007/s10552-018-1018-z – volume: 372 start-page: 2509 year: 2015 ident: ref_12 article-title: PD-1 Blockade in Tumors with Mismatch-Repair Deficiency publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1500596 – volume: 383 start-page: 2053 year: 2020 ident: ref_9 article-title: Endometrial Cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra1514010 – volume: 10 start-page: 143 year: 2022 ident: ref_33 article-title: A novel 12-gene prognostic signature in breast cancer based on the tumor microenvironment publication-title: Ann. Transl. Med. doi: 10.21037/atm-21-6748 – volume: 10 start-page: e003777 year: 2022 ident: ref_14 article-title: Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: Interim results from GARNET-a phase I, single-arm study publication-title: J. Immunother. Cancer doi: 10.1136/jitc-2021-003777 – volume: 35 start-page: 2535 year: 2017 ident: ref_13 article-title: Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2017.72.5952 – volume: 80 start-page: 311 year: 2002 ident: ref_17 article-title: Functional and structural characterization of the human gene BHLHB5, encoding a basic helix-loop-helix transcription factor publication-title: Genomics doi: 10.1006/geno.2002.6833 – volume: 165 start-page: 1092 year: 2016 ident: ref_38 article-title: Effector T Cells Abrogate Stroma-Mediated Chemoresistance in Ovarian Cancer publication-title: Cell doi: 10.1016/j.cell.2016.04.009 – volume: 18 start-page: 873 year: 2018 ident: ref_7 article-title: Management Strategies for Recurrent Endometrial Cancer publication-title: Expert Rev. Anticancer Ther. doi: 10.1080/14737140.2018.1491311 – volume: 6 start-page: e26476 year: 2017 ident: ref_29 article-title: Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data publication-title: Elife doi: 10.7554/eLife.26476 – volume: 73 start-page: 292 year: 2012 ident: ref_18 article-title: Bhlhb5 and Prdm8 form a repressor complex involved in neuronal circuit assembly publication-title: Neuron doi: 10.1016/j.neuron.2011.09.035 – volume: 357 start-page: 409 year: 2017 ident: ref_30 article-title: Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade publication-title: Science doi: 10.1126/science.aan6733 – volume: 24 start-page: 7767 year: 2020 ident: ref_35 article-title: Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer publication-title: J. Cell Mol. Med. doi: 10.1111/jcmm.15408 – volume: 10 start-page: 379 year: 2019 ident: ref_39 article-title: Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.00379 – ident: ref_40 doi: 10.1016/j.semcancer.2022.02.017 – ident: ref_6 – volume: 34 start-page: 65 year: 2015 ident: ref_22 article-title: Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): A novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma publication-title: Int. J. Gynecol. Pathol. doi: 10.1097/PGP.0000000000000106 – ident: ref_43 doi: 10.3390/ijms20194705 – volume: 71 start-page: 7 year: 2021 ident: ref_3 article-title: Cancer Statistics, 2021 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21654 – volume: 12 start-page: 5538 year: 2015 ident: ref_20 article-title: HAND2-mediated proteolysis negatively regulates the function of estrogen receptor α publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2015.4070 – volume: 102 start-page: 15545 year: 2005 ident: ref_25 article-title: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.0506580102 – volume: 295 start-page: 9596 year: 2020 ident: ref_21 article-title: The transcription factor HAND2 up-regulates transcription of the IL15 gene in human endometrial stromal cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.RA120.012753 – volume: 1705 start-page: 48 year: 2019 ident: ref_34 article-title: bHLH transcription factors in neural development, disease, and reprogramming publication-title: Brain Res. doi: 10.1016/j.brainres.2018.03.013 – volume: 23 start-page: 263 year: 2017 ident: ref_15 article-title: Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-16-0863 – volume: 11 start-page: 6047 year: 2021 ident: ref_47 article-title: Pancancer survival analysis of cancer hallmark genes publication-title: Sci. Rep. doi: 10.1038/s41598-021-84787-5 – volume: 14 start-page: 4485 year: 2021 ident: ref_31 article-title: Endometrial Tumors with MSI-H and dMMR Share a Similar Tumor Immune Microenvironment publication-title: OncoTargets Ther. doi: 10.2147/OTT.S324641 – volume: 17 start-page: 559 year: 2017 ident: ref_41 article-title: Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2017.49 – volume: 497 start-page: 67 year: 2013 ident: ref_10 article-title: The Cancer Genome Atlas Research Network. Integrated genomic characterization of endometrial carcinoma publication-title: Nature doi: 10.1038/nature12113 – volume: 6 start-page: pl1 year: 2013 ident: ref_45 article-title: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal publication-title: Sci. Signal. doi: 10.1126/scisignal.2004088 |
SSID | ssj0023259 |
Score | 2.39916 |
Snippet | Endometrial cancer (EC) rates are rising annually. Additional prediction markers need to be evaluated because only 10–20% of EC cases show an objective... Endometrial cancer (EC) rates are rising annually. Additional prediction markers need to be evaluated because only 10-20% of EC cases show an objective... |
SourceID | pubmedcentral proquest crossref |
SourceType | Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 7158 |
SubjectTerms | Cell growth Cytokines DNA methylation Endometrial cancer Endometrium Estrogens Genes Medical prognosis Proteins T cell receptors Transcription factors |
SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bSxwxFA5WKfSl9Eq3tSWF9kmCM5lMJnmQUmWWVXSRouDbkCvd4mbszir6C_q3ezKXdfehfc4Ncu7JOedD6AtTwjKnCmJlIQlTKiHaUU9AJpUxhZGqBYM5m_LJJTu5yq-20HSohYlplYNObBW1rU18I9-nXMROIeDAfLv5TSJqVPxdHSA0VA-tYA_aFmNP0A6oZAF8v3NYTs9_rEKwjLbwaSlYJcJzybtU-AwC__3Zr3kD-2dFGuHf143Uo-e5mTe5ZojGL9Dz3oPE3zuSv0RbLrxCTztMyYfX6M_h5HRSUorL-z7HNeDjBg9kcBbHp1es8PmiBu4Chpi3H-34OFaKOHwWM_TWyt-wChZ3dYENrBqrO2Aafe3i-pikN2vwLOAy2HruWggQfBQZafEGXY7Li6MJ6dEWiAExXBLKPWc2lUw6k6jUcWvzQsO1J876TPpCep9y69MMYh4vRK5AdKl2stB5ZqzM3qLtUAf3DmFwUSi3gidCOya8FMxmBraXTGuTaz9Ce8P1VqZvRR4RMa4rCEkiMap1YozQ19Xsm64Fxz_m7Q6UqnpBbKpHthmhz6thEKH4L6KCq2_bORBjJKC5RqjYoPDqvNiEe3MkzH62zbgleDigM9____AP6BmNdRMJJ1Tsou3l4tZ9BG9mqT_1LPoX1Xf4og priority: 102 providerName: ProQuest |
Title | BHLHE22 Expression Is Associated with a Proinflammatory Immune Microenvironment and Confers a Favorable Prognosis in Endometrial Cancer |
URI | https://www.proquest.com/docview/2686123115 https://www.proquest.com/docview/2687720870 https://pubmed.ncbi.nlm.nih.gov/PMC9266305 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1ZbxMxEB71EBIviFME2shI8IQW9vD6eKhQW21IEakqRKS8rey1rQYlG8imqP0F_duM9wiJWiRe9sX2rtcz4_nGngPgLVXCUKt4YCSXAVUqDLSNXYAyqYqCF1LVxWBG52w4pl8m6WQHumqj7QJW95p2vp7UeDn7cP3r5hMK_JG3ONFk_zj9Ma8QpiQ8SsUu7KNOYt4MG9H1fQLChrpsmj_wCPwG3bjA3xm9rZz-Is5tf8kNBTR4DI9a5EiOG1I_gR1bPoUHTS3Jm2dwezL8OszimGTXrW9rSc4q0i2_NcQfuRJFLpYL_E9khHl9wU7OfISIJSPvmbcR9kZUaUgTD1jhqIH6jcyiZ9aP985504pMS5KVZjG3dekPcuoZaPkcxoPs--kwaKssBAWK3yqImWPURJJKW4QqssyYlOuYidAal0jHpXMRMy5K0NZxQqQKRTbWVnKdJoWRyQvYKxelfQkEoUnMjGCh0JYKJwU1SYGvl1TrItWuB--75c2LNgW5r4Qxy9EU8cTIN4nRg3fr3j-b1Bv_6HfQUSrv-CfH-fvEMoh3e_Bm3Yyi4-9DVGkXV3UftC1C3LF6wLcovP6eT7693VJOL-sk3BKRDe6Vr_5zkq_hYewDJ0IWxOIA9lbLK3uIcGal-7DLJxyfYvC5D_sn2fnFt75XMGm_5uE_d8r7ww |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqVgguqLzE0gJGoidkNXEcJz4gVMqusnS34tBKewt-qou6SdlsC_0F_Jv-RsZ57OMAt57jR5T5ZjwTz8yH0HsmU8OsTIgRiSBMyoAoSx0BnZRaJ1rImgxmfMqzc_Z1Ek-20F1XC-PTKjubWBtqU2r_j_yQ8tR3CgEH5tPVT-JZo_ztakeh0cDixN7-gpCt-jj8AvI9oHTQPzvOSMsqQDTAbUEod5wZiN2F1YEMLTcmThQsH1jjIuES4VzIjQsj8O1dmsYSIEqVFYmKI2188yUw-TssAt8K9CeZrAK8iNbkbCGceYTHgjeJ9lEkgsPpj1kFbx8loSeXXz8CV37tZlbm2jE32EWPW_8UHzWAeoK2bPEUPWgYK2-foT-fs1HWpxT3f7cZtAUeVrgTsjXY_9jFEn-bl4BdgNusvsbHQ1-HYvHY5_-tFddhWRjcVB1WMGsgbwCS6tL6-T4FcFrhaYH7hSlntiYYwccepvPn6PxevvoLtF2UhX2JMDhAlJuUB6myLHUiZSbSsLxgSulYuR760H3eXLeNzj3fxmUOAY8XRr4ujB46WI6-ahp8_GPcfiepvFXzKl-BsofeLR-DgvpbF1nY8roeAxFMAHaxh5INCS_38y2-N58U04u61bcA_wks8qv_b_4WPczOxqN8NDw92UOPqK_QCDih6T7aXsyv7WvwmxbqTQ1WjL7ft3b8Bd7eLxw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIhAXVF5ioYCR6AlZmziJHweEoN2wSx_qgUq9BT_VRd2k3WyB_gL-E7-OcR7b3QPcerYTK55vxjPxzHwIvU2VsKlTnFjJJUmVioh21BPQSWUMN1I1ZDCHR2x8kn45zU430J--FiakVfY2sTHUtjLhH_mQMhE6hYADM_RdWsTxXv7h4pIEBqlw09rTabQQ2XfXPyF8q99P9kDWO5Tmo6-7Y9IxDBAD0FsQyjxLLcTx0plIxY5Zm3ENS0XO-kR6Lr2PmfVxAn6-FyJTAFeqneQ6S4wNjZjA_N_hCZchnVDkn5fBXkIborYYzj_CMsnapPskkdFw-n1Ww5ckPA5E86vH4Y2Pu56huXLk5VvoQeer4o8tuB6iDVc-Qndb9srrx-j3p_HBeEQpHv3qsmlLPKlxL3BncfjJixU-nleAY4DerLnSx5NQk-LwYcgFXCm0w6q0uK1ArOGpXP0AeOpzF54P6YDTGk9LPCptNXMN2QjeDZCdP0Ent7LrT9FmWZXuGcLgDFFmBYuEdqnwUqQ2MfB6mWptMu0H6F2_vYXpmp4H7o3zAoKfIIxiVRgDtLOcfdE2-_jHvO1eUkWn8nVxA9ABerMcBmUNNzCqdNVVMweimQhs5ADxNQkv1wvtvtdHyulZ0_Zbgi8F1vn5_xd_je6BXhQHk6P9F-g-DcUaESNUbKPNxfzKvQQXaqFfNVjF6NttK8dfpGIzUQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=BHLHE22+Expression+Is+Associated+with+a+Proinflammatory+Immune+Microenvironment+and+Confers+a+Favorable+Prognosis+in+Endometrial+Cancer&rft.jtitle=International+journal+of+molecular+sciences&rft.au=Darmawi&rft.au=Chen%2C+Lin-Yu&rft.au=Su%2C+Po-Hsuan&rft.au=Liew%2C+Phui-Ly&rft.date=2022-06-28&rft.issn=1422-0067&rft.eissn=1422-0067&rft.volume=23&rft.issue=13&rft.spage=7158&rft_id=info:doi/10.3390%2Fijms23137158&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_ijms23137158 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1422-0067&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1422-0067&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1422-0067&client=summon |